These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 15838271)
1. Influence of endothelin receptor antagonism on smooth muscle cell proliferation after chronic renal failure. Sauter G; Wolf S; Risler T; Brehm B J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S165-7. PubMed ID: 15838271 [TBL] [Abstract][Full Text] [Related]
2. Influence of growth factors on the proliferation of vascular smooth muscle cells isolated from subtotally nephrectomized rats after endothelin or angiotensin II antagonism. Wolf SC; Sauter G; Rodemann HP; Risler T; Brehm BR Nephrol Dial Transplant; 2005 Feb; 20(2):312-8. PubMed ID: 15585510 [TBL] [Abstract][Full Text] [Related]
3. Effects of combined endothelin and angiotensin II antagonism on growth factor-induced proliferation of vascular smooth muscle cells isolated from uremic rats. Wolf SC; Sauter G; Risler T; Brehm BR Ren Fail; 2005; 27(4):465-74. PubMed ID: 16060137 [TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor receptor transactivation by endogenous vasoactive peptides contributes to hyperproliferation of vascular smooth muscle cells of SHR. Li Y; Lévesque LO; Anand-Srivastava MB Am J Physiol Heart Circ Physiol; 2010 Dec; 299(6):H1959-67. PubMed ID: 20852045 [TBL] [Abstract][Full Text] [Related]
5. Endothelin-1 induces pulmonary but not aortic smooth muscle cell migration by activating ERK1/2 MAP kinase. Meoli DF; White RJ Can J Physiol Pharmacol; 2010 Aug; 88(8):830-9. PubMed ID: 20725141 [TBL] [Abstract][Full Text] [Related]
6. Chronic treatment with PDGF-BB and endothelin-1 synergistically induces vascular hyperplasia and loss of contractility in organ-cultured rat tail artery. Kida T; Chuma H; Murata T; Yamawaki H; Matsumoto S; Hori M; Ozaki H Atherosclerosis; 2011 Feb; 214(2):288-94. PubMed ID: 21129745 [TBL] [Abstract][Full Text] [Related]
7. Endothelin-1 stimulates proliferation of human coronary smooth muscle cells via the ET(A) receptor and is co-mitogenic with growth factors. Hafizi S; Allen SP; Goodwin AT; Chester AH; Yacoub MH Atherosclerosis; 1999 Oct; 146(2):351-9. PubMed ID: 10532691 [TBL] [Abstract][Full Text] [Related]
8. Antiproliferative activity of NQ304, a synthetic 1,4-naphthoquinone, is mediated via the suppressions of the PI3K/Akt and ERK1/2 signaling pathways in PDGF-BB-stimulated vascular smooth muscle cells. Kim TJ; Yun YP Vascul Pharmacol; 2007 Jan; 46(1):43-51. PubMed ID: 16875883 [TBL] [Abstract][Full Text] [Related]
9. A role for platelet-derived growth factor beta-receptor in a newborn rat model of endothelin-mediated pulmonary vascular remodeling. Jankov RP; Kantores C; Belcastro R; Yi S; Ridsdale RA; Post M; Tanswell AK Am J Physiol Lung Cell Mol Physiol; 2005 Jun; 288(6):L1162-70. PubMed ID: 15722379 [TBL] [Abstract][Full Text] [Related]
14. Oral Platelet-Derived Growth Factor and Vascular Endothelial Growth Factor Inhibitor Sunitinib Prevents Chronic Allograft Injury in Experimental Kidney Transplantation Model. Rintala JM; Savikko J; Palin N; Rintala SE; Koskinen PK; von Willebrand E Transplantation; 2016 Jan; 100(1):103-10. PubMed ID: 26262503 [TBL] [Abstract][Full Text] [Related]
15. Carvacrol inhibits atherosclerotic neointima formation by downregulating reactive oxygen species production in vascular smooth muscle cells. Lee KP; Sudjarwo GW; Jung SH; Lee D; Lee DY; Lee GB; Baek S; Kim DY; Lee HM; Kim B; Kwon SC; Won KJ Atherosclerosis; 2015 Jun; 240(2):367-73. PubMed ID: 25875388 [TBL] [Abstract][Full Text] [Related]
16. 2,3,4',5-Tetrahydroxystilbene-2-O-β-d-glucoside inhibits platelet-derived growth factor-induced proliferation of vascular smooth muscle cells by regulating the cell cycle. Xu XL; Huang YJ; Wang YQ; Chen XF; Zhang W Clin Exp Pharmacol Physiol; 2011 May; 38(5):307-13. PubMed ID: 21348889 [TBL] [Abstract][Full Text] [Related]